KEGG pathway analysis revealed that the toll-like receptors, HIF-1, PIK3K/AKT, MAPK, NF-κB, and NOD-like receptor signaling pathways had significant effects on COVID-19 therapy. This evidence concerns the gene NFKB1 and COVID-19.